https://www.avient.com/sites/default/files/2024-01/AVNT January IR Presentation_w Non-Gaap Recs.pdf
Avient corporation first quarter 2023 results AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) J A N UA RY 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
PRIOR YEAR $790 $710 2022 2023 $107 $112 2022 2023 Sales Adjusted EBITDA (in millions) $0.42 $0.47 2022 PF 2023 Adjusted EPS (in millions) - 10% + 5% + 12% Sales Adjusted EBITDA Adjusted EPS 16 $112 $500 Q4 FY $0.47 $2.30 Q4 FY Q4 AND FULL YEAR 2023 GUIDANCE $710 $3,130 Q4 FY Sales Adjusted EBITDA Adjusted EPS 17 (in millions) (in millions) Guidance: Free Cash Flow $180 $180 Prior Guidance Guidance FREE CASH FLOW & INCREASED DIVIDEND 13th Consecutive Dividend Increase 0.16 0.26 0.42 0.58 0.79 0.85 0.99 1.03 2011 2013 2015 2017 2019 2021 2023 2024 18 S U S TAI NABI L I T Y DAY RE CAP SUSTAINABILITY AS A GROWTH DRIVERLONG-TERM REVENUE GROWTH DRIVERS 60%+ Key Growth Drivers Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other (GDP Growth) Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other (GDP growth) 0–2% Avient 6% 20 SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 8-12% Long Term Growth 50 90 2022 2030 Medical Plastics Market Size (in $Billions) 2020 2030 Recycled Plastics Virgin Plastics Growing Demand for Recycled Content Avient Sustainable Solutions 18 46 2023 2032 Global Offshore Annual Wind Installations (in Gigawatts) Sources: McKinsey, Bloomberg, Grand View Research SUSTAINABILITY TRENDS DRIVE LONG-TERM GROWTH 21 • Transformative acquisitions combined with divestitures of more cyclical businesses have improved margins over 400 bps since 2018 • 20% long-term margin goal to be driven by key growth drivers, with sustainable solutions playing a meaningful role 5.4% 11.5% 16.0% 2006 2018 2023E Recovery Growth Drivers Strategic Objective 20%+ +1%+ +3%+ ADJUSTED EBITDA MARGIN EXPANSION 22 • 6% annualized long-term sales growth leveraging sustainable solutions, composites, healthcare, and emerging regions • Expand EBITDA margins to 20% • Deliver annual EBITDA and EPS growth of 10% and 15% • Maintain asset-light, 80% free cash flow conversion profile and be valued as a specialty formulator • Continue fostering our Great Place to Work® culture CREATING A WORLD-CLASS SUSTAINABLE ORGANIZATION 23 PEER COMPARISONS AVIENT IS ASSET LIGHT Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of December 29, 2023 Note: Avient reflects 2023 estimated revenue of $3,130 and estimated run-rate CAPEX of $110M. 26 3.5 1.8 2.7 3.1 3.3 3.7 3.0 3.7 4.7 4.8 6.8 6.8 8.7 11.1 Av ie nt KW R FU L PP G AV Y R PM FM C H U N C E EC L H XL AS H EM N SC L FREE CASH FLOW CONVERSION Source: Peer data per Bloomberg as of December 29, 2023 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA.
Avient reflects 2023 adjusted EBITDA guidance of $500M and estimated run-rate CAPEX of $110M. 2023E (%) 27 78 89 83 80 78 74 86 79 76 67 66 55 50 (39) Av ie nt KW R FU L PP G AV Y R PM FM C C E EC L AS H H XL H U N EM N SC L Avient Specialty Formulators Other Specialty / Chemical Companies MULTIPLE EXPANSION Source: Peer data per Bloomberg as of December 29, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $500M and closing share price of $41.57.
https://www.avient.com/products/fiber-line-engineered-fiber-solutions/fiber-line-performance-enhancing-processes/polymer-jacket-extrusion
70 ̊C -125 ̊C
https://www.avient.com/knowledge-base/case-study/cutting-edge-product-development-rada-cutlery
With 70+ years in business and over 165 million knives made, Rada Cutlery has earned and delivered on a reputation for remarkable quality and tremendous value.
https://www.avient.com/knowledge-base/case-study/pain-therapy-device-stands-out-peers?rtype[]=1124
Creating a two cavity tool for the bumpers saved PTA 70% over the cost of an overmolding tool, and reduced scrap rates typical with overmolded housings by 80%.
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-june-2021-w-non-gaap-recs_0.pdf
D is t. ) K W R R P M P P G A V Y F U L G C P H X L F M C F O E IF F H U N E C L A S H E M N K R A C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of June 4, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 78% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of June 4, 2021 87 89 87 86 83 81 76 88 85 83 82 81 80 78 78 78 76 72 71 69 50 18 A vi en t K W R P P G R P M A V Y F U L G C P F M C H X L U N V R IF F E C L A S H F O E C E E M N B N R H U N G R A K R A S C L A L B Source: Peer data per Bloomberg market data as of June 4, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.4 18.2 16.0 15.5 15.3 11.3 11.0 29.7 26.5 23.5 18.2 13.4 11.9 11.9 11.7 10.5 10.4 10.3 10.1 9.7 7.7 6.5 A vi en t K W R A V Y P P G R P M F U L G C P H X L A L B E C L IF F F M C B N R A S H G R A E M N F O E S C L U N V R C E K R A H U N Median: 11.7xMedian: 15.4x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/knowledge-base/article/apparent-hardness-vs-thickness-overmold-applications?rtype[]=1164
70
https://www.avient.com/news/polyone-showcases-solutions-efficient-manufacturing-wire-2014
Next-generation FireCon™ CPE (chlorinated polyethylene) RoHS-compliant material for wire and cable jacketing that processes 30% to 70% faster and reduces scrap for improved profitability without compromising performance
https://www.avient.com/knowledge-base/article/apparent-hardness-vs-thickness-overmold-applications
70
https://www.avient.com/sites/default/files/2025-05/Versaflex TPE-snorkel mouthpiece- case study snapshot.pdf
SPORTS BRAND
S N O R K E L M O U T H P I E C E
• Replace PVC with alternative materials such as TPE or
silicone
• Skin contact safety and UV resistance
• Soft texture with a non-sticky feel
• Translucent color to help children use it properly and
safely
• Customized a soft (Shore A) TPE solution that
passed strict tests, including thermal
deformation (80°C for 2 hours), UV resistance,
and assembly resistance
• Providing a 40% more cost-effective system
than silicone due to the high production
efficiencies of TPEs
• Provided cross-regional cooperation and prompt
response to help customers achieve fast
commercialization in both Europe and China
Versaflex Thermoplastic Elastomers
UV RESISTANT + TRANSLUCENT
Copyright © 2025, Avient Corporation.
https://www.avient.com/sites/default/files/2025-05/Bergamid Crane Control Housing case study snapshot.pdf
INDUSTRIAL EQUIPMENT MANUFACTURER H O U S I N G F O R C R A N E C O N T R O L • High impact performance, charpy notched > 60kJ/m2 • Part assembly: tight dimensional tolerances ±0.05mm • Critical weld lines are invisible on the final part • Red RAL 3020 as branding color • Color stability during injection • Offered a nylon (PA66) formulation with high impact resistance and dimensional stability • Supported injection trials with field technical services • Developed a ready-to-use solution in RAL 3020 with excellent color stability, helping to reduce scrap rate from >50% to 4% • Enabled timely production through fast new developments and samplings • Offered additional color options Bergamid Polyamide Formulations KEY REQUIREMENTS WHY AVIENT?